12,372 trials
Jawline Definition
Primary: Percentage of Participants Who Show ≥ 1-point Jawline Improvement on Both Sides From Baseline on the Allergan Loss of Jawline Definition Scale (ALJDS) — 38.0; 69.0…
Pancreatic Cancer Metastatic
Primary: Overall Survival (OS) — 11.10; 11.73 months
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Primary: Phase A: Change From Baseline in Spot Urine Osmolality (Pre-morning Dose) — 635; 646; -386; -93 milliosmoles per kilogram (mOsm/kg)
Growth Disorders
Primary: Annual Height Velocity — 9.43; 10.70 cm/year
Chronic Spontaneous Urticaria
Primary: Mean Change From Baseline in UAS7 at Week 12 (Multiple Imputation) of Adult Subjects — -19.368; -19.330; -20.040; -11.366 Score — p=<.0001
Coronary Artery Disease · Myocardial Perfusion Abnormalities
Primary: Number of Participants With Coronary Stenosis — 50 Participants
Obesity · Weight Loss · Eating Behavior
Primary: Attentional Bias — 48.85 percentage of time fixated on food cues
Chronic Kidney Diseases · Heart Attack · Stroke, Ischemic
Primary: ADP Induced Platelet Aggregation — 0; 6; 1 ohms — p=0.002
Eosinophilic Esophagitis
Primary: Percentage of Participants Achieving Peak Esophageal Intraepithelial Eosinophil Count of ≤6 Eosinophils Per High-power Field (Eos/Hpf) in All Three Regions at Week 24…
Generalized Anxiety Disorder
Primary: Change From Baseline in the HAM-A Total Score at Week 8 — -9.28; -9.35 score on a scale — p=0.917
Molluscum Contagiosum
Primary: Complete Clearance of All Treatable MC at Week 12 — 61; 25 Participants
Cold Agglutinin Disease
Primary: Part A: Percentage of Participants With Response to Treatment — 72.7; 15.0 percentage of participants — p=<0.001
Anxiety Disorders · Panic Disorder · Agoraphobia
Primary: Panic Disorder Severity Scale — 6.72; 5.78; 7 score on a scale — p=>0.16
SARS-CoV-2 Infection · COVID-19
Primary: Geometric Mean Titers (GMTs) of Full-Length S-Binding IgG Concentrations of Lyophilized Formulation SDVs and Frozen-Liquid Formulation in MDVs 1 Month After Dose 2…
Cataract
Primary: Anterior Chamber Cell Grade — 67; 18 Participants